Go to content Go to the menu Go to the search

Institute of Longevity

Quick access, personalized services


Advanced search

Long Live the Charles Foix Institute of Longevity!

inauguration de l'institut de la longévité

The first stone of the Charles Foix Institute of Longevity was laid on Thursday, February 17, at the Charles Foix hospital, in the presence of: Jean Mariani, Scientific Director, Jean-Paul Huchon, President of the Île-de-France regional council, Alain Desmarest, 1st Vice President of the Val-de-Marne general council, Pierre Gosnat, Deputy Mayor of Ivry-sur-Seine, Jean-Marie Le Guen, Acting President of the AP-HP board, and Jean-Charles Pomerol, UPMC President. An opportunity for M. Pomerol to underline UPMC’s important human and financial investment in this project, while expressing satisfaction in the support given by the local and scientific partners involved to further research into ageing.

The Institute in brief: live longer and age better

In France, the increase in life expectancy and the consequences arising from it are an increasing concern for both researchers and the public. Considerable efforts have been made for several years in the Île-de-France region by the AP-HP (Public Assistance-Paris Hospitals), UPMC and sub-regional councils to allow a real emulation in the field of gerontology, in terms of research, teaching and valorization. These coordinated activities must aim for the promotion of “ageing well” and the preservation of autonomy, which entails the prevention of the major afflictions of advancing age such as neuropsychiatric diseases, cardiovascular disease and cancer.

Renowned economic partners, stepping up to a major challenge: the ageing of the population

The Charles Foix Institute of Longevity was born of an encounter between scientific and institutional partners, associations and local councils, representing a new hope for many sick people and an innovative response to this fundamental social issue. This project, which is run by the UPMC and accommodated on the AP-HP’s Charles Foix Geriatric Hospital site, is financed by 2 successive state/region project contracts of 17 million euros. It is an investment equal to the challenge represented by this centre, which is part of both the economic development policy of the region, the department and the cities of Ivry-sur-Seine and Vitry-sur-Seine, and the university hospital development of South-East Paris.

Innovation in support of longevity

The goal of the Charles Foix Institute of Longevity will be to develop fundamental and clinical research into longevity and diseases related to ageing (Alzeimer’s, cardiovascular diseases…). It will also encourage innovation, technology valorization and professional training thanks to the setting up of a research centre and a business incubator for biotechnology and gerontechnology. Eventually, this unique operation will allow new therapies to be tested which are better adapted to older persons’ needs, and the development of new technologies to facilitate the daily life of dependant persons and improve their autonomy.

To learn more:

Read an interview with Jean Mariani